EMA - European Medicines Agency · March 30, 2023

PRAC meeting highlights, 6–9 July 2026

Original title: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026

Low obligation Framework Pharmaceuticals EU-wide Pharmacovigilance

PRAC agrees new safety information on desogestrel- and etonogestrel-containing contraceptives and Litfulo, a medicine to treat alopecia areata   Desogestrel- and etonogestrel-…, Agenda Agenda of the PRAC meeting 6-9 July 2026Draft Reference Number: EMA/PRAC/141965/2026…, PRAC statistics: July 2026 , PRAC statistics: July 2026 English (EN) (174.12 KB - PDF)First published: 10/07/2026 View , Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association between…

Dates and deadlines

Regulatory Deadline

October 07, 2026

Read the official source ↗

Published by EMA - European Medicines Agency. HealthSignal links to the original document; the summary above is extracted from the source text.